Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feinberg

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Harm Reduction Journal|August 24, 2024
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiativeSuzan M Walters, Robin Baker, David Frank, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
The International Journal on Drug Policy|October 8, 2023
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communitiesAngela T Estadt, William C Miller, David Kline, et al.
AIDS and Behavior|July 29, 2023
Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018-2020Umedjon Ibragimov, Melvin D Livingston, April M Young, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
Drug and Alcohol Dependence|November 24, 2024
Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid InitiativeApril M Ballard, Zora Kesich, Heidi M Crane, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.
Research Square|June 30, 2025
Genomic surveillance uncovers regional variation in HCV transmission networks among people who use drugs in rural U.S. communitiesDamien Tully, David Bean, Jacklyn Sarette, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Harm Reduction Journal|August 24, 2024
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiativeSuzan M Walters, Robin Baker, David Frank, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
The International Journal on Drug Policy|October 8, 2023
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communitiesAngela T Estadt, William C Miller, David Kline, et al.
AIDS and Behavior|July 29, 2023
Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018-2020Umedjon Ibragimov, Melvin D Livingston, April M Young, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
Drug and Alcohol Dependence|November 24, 2024
Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid InitiativeApril M Ballard, Zora Kesich, Heidi M Crane, et al.
International Journal of Environmental Research and Public Health|January 28, 2026
Impact of Social Drivers of Health, Self-Efficacy, and Substance Use on COVID-19 Preventative Behaviors Among Persons Who Inject Drugs with Hepatitis C: The HERO StudySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
The Journal of Infectious Diseases|February 28, 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patientsConstance A Benson, Steven G Deeks, Scott C Brun, et al.
Research Square|June 30, 2025
Genomic surveillance uncovers regional variation in HCV transmission networks among people who use drugs in rural U.S. communitiesDamien Tully, David Bean, Jacklyn Sarette, et al.
Pageof 17